Stay updated with breaking news from Use Authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
21.12.2022 - Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Actemra (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adult patients ... Seite 1
SOUTH SAN FRANCISCO (dpa-AFX) - The U.S. Food and Drug Administration has approved Roche's (RHHBY) Actemra (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adult patients
The Consumer Technology Association (CTA) awards Abbott multiple CES 2023 Innovation Awards for industry-leading health technologiesAbbott's Aveir single-chamber (VR) leadless pacemaker, Proclaim Plus
Actemra is the first FDA-approved monoclonal antibody to treat COVID-19 Since the beginning of the pandemic, more than one million people hospitalised with COVID-19 have been treated with Actemra worldwide
/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...